532 related articles for article (PubMed ID: 26520171)
1. Topical Fluorometholone Protects the Ocular Surface of Dry Eye Patients from Desiccating Stress: A Randomized Controlled Clinical Trial.
Pinto-Fraga J; López-Miguel A; González-García MJ; Fernández I; López-de-la-Rosa A; Enríquez-de-Salamanca A; Stern ME; Calonge M
Ophthalmology; 2016 Jan; 123(1):141-53. PubMed ID: 26520171
[TBL] [Abstract][Full Text] [Related]
2. Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears.
Nättinen J; Jylhä A; Aapola U; Enríquez-de-Salamanca A; Pinto-Fraga J; López-Miguel A; González-García MJ; Stern ME; Calonge M; Zhou L; Nykter M; Uusitalo H; Beuerman R
Ocul Surf; 2018 Jan; 16(1):84-92. PubMed ID: 28918083
[TBL] [Abstract][Full Text] [Related]
3. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Zhu L; Zhang C; Chuck RS
Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633
[TBL] [Abstract][Full Text] [Related]
4. Severity, therapeutic, and activity tear biomarkers in dry eye disease: An analysis from a phase III clinical trial.
Pinto-Fraga J; Enríquez-de-Salamanca A; Calonge M; González-García MJ; López-Miguel A; López-de la Rosa A; García-Vázquez C; Calder V; Stern ME; Fernández I
Ocul Surf; 2018 Jul; 16(3):368-376. PubMed ID: 29772277
[TBL] [Abstract][Full Text] [Related]
5. Lifitegrast Ophthalmic Solution 5.0% versus Placebo for Treatment of Dry Eye Disease: Results of the Randomized Phase III OPUS-2 Study.
Tauber J; Karpecki P; Latkany R; Luchs J; Martel J; Sall K; Raychaudhuri A; Smith V; Semba CP;
Ophthalmology; 2015 Dec; 122(12):2423-31. PubMed ID: 26365210
[TBL] [Abstract][Full Text] [Related]
6. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
[TBL] [Abstract][Full Text] [Related]
7. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
Toker E; Asfuroğlu E
Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564
[TBL] [Abstract][Full Text] [Related]
8. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
9. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
10. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation.
Davitt WF; Bloomenstein M; Christensen M; Martin AE
J Ocul Pharmacol Ther; 2010 Aug; 26(4):347-53. PubMed ID: 20653478
[TBL] [Abstract][Full Text] [Related]
11. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.
Li L; Jin R; Li Y; Yoon HS; Yoon HJ; Yoon KC
Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685
[TBL] [Abstract][Full Text] [Related]
12. A clinical evaluation of Systane.
Gifford P; Evans BJ; Morris J
Cont Lens Anterior Eye; 2006 Mar; 29(1):31-40. PubMed ID: 16473547
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of hypotonic 0.18% sodium hyaluronate eye drops in patients with dry eye disease.
Lee HS; Ji YS; Yoon KC
Cornea; 2014 Sep; 33(9):946-51. PubMed ID: 24915018
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride].
He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG
Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914
[TBL] [Abstract][Full Text] [Related]
15. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
[TBL] [Abstract][Full Text] [Related]
16. Effects of Prolonged Reading on Dry Eye.
Karakus S; Agrawal D; Hindman HB; Henrich C; Ramulu PY; Akpek EK
Ophthalmology; 2018 Oct; 125(10):1500-1505. PubMed ID: 29705055
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib (CP-690,550), a Janus kinase inhibitor for dry eye disease: results from a phase 1/2 trial.
Liew SH; Nichols KK; Klamerus KJ; Li JZ; Zhang M; Foulks GN
Ophthalmology; 2012 Jul; 119(7):1328-35. PubMed ID: 22525048
[TBL] [Abstract][Full Text] [Related]
18. Ocular surface tolerability of prostaglandin analogs in patients with glaucoma or ocular hypertension.
Whitson JT; Trattler WB; Matossian C; Williams J; Hollander DA
J Ocul Pharmacol Ther; 2010 Jun; 26(3):287-92. PubMed ID: 20578283
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of eyedrops containing cross-linked hyaluronic acid and coenzyme Q10 in treating patients with mild to moderate dry eye.
Postorino EI; Rania L; Aragona E; Mannucci C; Alibrandi A; Calapai G; Puzzolo D; Aragona P
Eur J Ophthalmol; 2018 Jan; 28(1):25-31. PubMed ID: 28777385
[TBL] [Abstract][Full Text] [Related]
20. Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China.
Lin T; Gong L
Medicine (Baltimore); 2015 Feb; 94(7):e551. PubMed ID: 25700323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]